If you made any changes in Pure these will be visible here soon.

Fingerprint Dive into the research topics where Saverio Minucci is active. These topic labels come from the works of this person. Together they form a unique fingerprint.

  • 39 Similar Profiles
Histone Deacetylases Medicine & Life Sciences
Acute Promyelocytic Leukemia Medicine & Life Sciences
Histone Deacetylase Inhibitors Medicine & Life Sciences
Epigenomics Medicine & Life Sciences
Tretinoin Medicine & Life Sciences
Neoplasms Medicine & Life Sciences
Leukemia Medicine & Life Sciences
Retinoic Acid Receptors Medicine & Life Sciences

Network Recent external collaboration on country level. Dive into details by clicking on the dots.

Research Output 1989 2019

Author Correction: Differential epigenetic reprogramming in response to specific endocrine therapies promotes cholesterol biosynthesis and cellular invasion (Nature Communications, (2015), 6, 1, (10044), 10.1038/ncomms10044)

Nguyen, V. T. M., Barozzi, I., Faronato, M., Lombardo, Y., Steel, J. H., Patel, N., Darbre, P., Castellano, L., Győrffy, B., Woodley, L., Rodriguez-Meira, A., Patten, D. K., Vircillo, V., Periyasamy, M., Ali, S., Frige, G., Minucci, S., Coombes, R. C. & Magnani, L., Dec 1 2019, In : Nature Communications. 10, 1, 3505.

Research output: Contribution to journalComment/debate

Open Access

Identification of mutations associated with acquired resistance to sunitinib in renal cell cancer

Elgendy, M., Fusco, J. P., Segura, V., Lozano, M. D., Minucci, S., Echeveste, J. I., Gurpide, A., Andueza, M., Melero, I., Sanmamed, M. F., Ruiz, M. R., Calvo, A., Pascual, J. I., Velis, J. M., Miñana, B., Valle, R. D., Pio, R., Agorreta, J., Abengozar, M., Colecchia, M. & 5 others, Brich, S., Renne, S. L., Guruceaga, E., Patiño-García, A. & Perez-Gracia, J. L., Jan 1 2019, In : International Journal of Cancer. 145, 7, p. 1991-2001 11 p.

Research output: Contribution to journalArticle

Renal Cell Carcinoma
Tumor Suppressor Genes
Triple Negative Breast Neoplasms
Breast Neoplasms
United States Food and Drug Administration

Rad51/BRCA2 disruptors inhibit homologous recombination and synergize with olaparib in pancreatic cancer cells

Roberti, M., Schipani, F., Bagnolini, G., Milano, D., Giacomini, E., Falchi, F., Balboni, A., Manerba, M., Farabegoli, F., De Franco, F., Robertson, J., Minucci, S., Pallavicini, I., Di Stefano, G., Girotto, S., Pellicciari, R. & Cavalli, A., Mar 1 2019, In : European Journal of Medicinal Chemistry. 165, p. 80-92 13 p.

Research output: Contribution to journalArticle

Homologous Recombination
Pancreatic Neoplasms